Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial-Reference-Cited by-同舟云学术

Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial

Published:2014-12 Issue:1 Volume:15 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Fowler Robert A,Mittmann Nicole,Geerts William H,Heels-Ansdell Diane,Gould Michael K,Guyatt Gordon,Krahn Murray,Finfer Simon,Pinto Ruxandra,Chan Brian,Ormanidhi Orges,Arabi Yaseen,Qushmaq Ismael,Rocha Marcelo G,Dodek Peter,McIntyre Lauralyn,Hall Richard,Ferguson Niall D,Mehta Sangeeta,Marshall John C,Doig Christopher James,Muscedere John,Jacka Michael J,Klinger James R,Vlahakis Nicholas,Orford Neil,Seppelt Ian,Skrobik Yoanna K,Sud Sachin,Cade John F,Cooper Jamie,Cook Deborah

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/1745-6215-15-502.pdf

Reference40 articles.

1. Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts W: Deep vein thrombosis and its prevention in critically ill patients. Arch Intern Med. 2001, 161: 1268-1279. 10.1001/archinte.161.10.1268.

2. Geerts W, Selby R: Prevention of venous thromboembolism in the ICU. Chest. 2004, 124: 357S-363S.

3. Barritt DW, Jordan SC: Anticoagulant drugs in the treatment of pulmonary embolism. A Contr Trial Lancet. 1960, i: 1309-1312.

4. Crowther MA, Cook DJ, Griffith LE, Devereaux PJ, Rabbat CC, Clarke FJ, Hoad McDonald E, Meade MO, Guyatt GH, Geerts WH, Wells PS: Deep venous thrombosis: clinically silent in the intensive care unit. J Crit Care. 2005, 20: 334-340. 10.1016/j.jcrc.2005.09.011.

5. Sud S, Mittmann N, Cook DJ, Geerts W, Chan B, Dodek P, Gould MK, Guyatt G, Arabi Y, Fowler RA, On behalf of the E-PROTECT investigators and the Canadian critical care trials group: Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med. 2011, 184: 1289-1298. 10.1164/rccm.201106-1059OC.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): a cost-effectiveness analysis;Canadian Journal of Anesthesia/Journal canadien d'anesthésie;2022-10-26

2. Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial;CMAJ Open;2022-07

3. Thromboprophylaxis in critically ill patients: balancing on a tightrope;Minerva Anestesiologica;2021-11

4. Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol;BMJ Open;2020-06

5. Cost-Effectiveness Studies in the ICU;Critical Care Medicine;2019-08